As Trump Pushes a Bigger Iran War Budget, 3 Core Defense Holdings Stand Out for Patient Investors

The article is broadly constructive on Lockheed Martin, Northrop Grumman, and RTX, citing multiyear defense demand, large backlogs, and major programs such as the F-35, Sentinel, and B-21. Lockheed highlighted $194 billion in backlog and $6.5 billion to $6.8 billion in expected fiscal 2026 free cash flow, while RTX reported a record $268 billion backlog and $7.9 billion in fiscal 2025 free cash flow. The backdrop includes a possible U.S. defense budget near $1.5 trillion for 2027, but the piece is opinion-oriented rather than a new company-specific catalyst.

Analysis

The market is likely underestimating how much of the near-term upside in defense names is already in the backlog and how much remains in production-rate expansion. The real second-order beneficiaries are not just the primes, but suppliers tied to propellant, guidance, avionics, and specialty materials: when programs move from development to throughput mode, the bottlenecks shift from win-rate to manufacturing yield, which typically expands margins for the best-positioned subcontractors. That dynamic should favor companies with pricing power and process control, while smaller legacy platforms tied to flat-volume fleets will lag.

The biggest catalyst is not the headline budget number, but the conversion of political intent into multi-year procurement authority. If funding gets delayed, these stocks can still work because the backlog provides a floor; if funding accelerates, the upside comes from faster build rates and higher free cash flow conversion rather than just higher revenue. The key timing issue is that sentiment can stay bid for months on geopolitical tension, but the higher-quality rerating usually arrives only when appropriations and production ramp confirmations hit.

A more contrarian read is that the defense trade is becoming crowded precisely when investors are treating it as a simple geopolitical hedge. The consensus is paying for durability, but not enough for execution risk: any slippage in missile production, test schedules, or cost growth could compress multiples even with strong demand. RTX has the cleanest relative setup because it has both defense and civil cyclicality, but that also means it is less of a pure conflict hedge and more of a macro-portfolio compounder.

For now, the trade is less about chasing crisis beta and more about owning durable compounding cash flows with visible capacity expansion. The risk/reward is best where backlog converts into incremental production capacity over the next 6-18 months, and worst where investors are extrapolating headline spending without accounting for procurement timing, supply-chain constraints, or post-event mean reversion.

Key Decisions for Investors

• Long RTX vs. LMT over the next 3-6 months: RTX offers a cleaner blend of defense rearmament and civil aviation recovery, with better diversification if geopolitical headlines fade; LMT is more levered to program execution and budget timing.
• Buy LMT on pullbacks near support, targeting a 6-12 month horizon: the setup is most attractive if production-rate announcements translate into margin expansion, but trim if the stock begins to price in flawless PAC-3 execution.
• Pair trade: long prime contractors with backlog conversion, short lower-quality defense services/legacy integrators that lack multiyear production ramps; the spread should widen if appropriations accelerate and procurement turns into volume, not just rhetoric.
• Use call spreads on NOC into the 6-12 month window: the best upside comes from Sentinel/B-21 de-risking, but the valuation is vulnerable if test milestones slip, so defined-risk exposure is preferable to stock outright.
• Avoid chasing the headline on defense as a blanket hedge; fade any 1-2 day geopolitical spikes by selling upside calls against existing longs if implied volatility becomes expensive relative to the likely 30-90 day policy lag.